This week, London hosted the third annual Antibiotic Guardian Awards: an event to recognise individuals and organisations who are successfully tackling antimicrobial resistance (AMR) at a local, regional and national level.
We were shortlisted in the ‘Public Engagement and Education’ category for our ABPI education programme for schools which highlights what the ABPI – and our industry – is doing in the fight against antimicrobial resistance.
AMR is the greatest public health threat facing the world and one of the greatest contributing factors to AMR is the inappropriate use of antibiotics.
At the ABPI, our recent audit of how and where AMR features within school curriculum found there was more we could be doing to help teach 5 – 16+ year olds about its threat and spread.
In November 2017, we launched free, interactive digital resources on our award winning ABPI Schools website to support students and teachers. Just 6 months on, our materials have gone global. They’ve been accessed across the UK and in the United States, Australia, Canada, New Zealand and Kazakhstan. Our commitment in this area does not end here.
Crucially, we’re asking users to help us improve our resources as they use them, so we know what works and what we can make even more useful.
Tackling AMR is a global issue and as an industry we have a role to play in developing more antibiotics and ensuring that antibiotics are used appropriately. Together, we’re helping fight AMR one lesson at a time.
That’s why reports which suggest industry is not doing its part just aren’t true. Globally, over 100 companies signed up to the Davos Declaration which commits our industry to actively tackle AMR.
Furthermore, in the UK, our members are working to deliver on the Davos commitments; supporting awareness campaigns, such as the Pfizer-sponsored exhibition at the Science Museum, contributing to the understanding of AMR through data studies and ensuring that health care professionals appropriately use existing antibiotics.
More antimicrobials are in development and we’re working with Governments to improve awareness and support appropriate use guidance. But there’s more to do and we’re going to keep working to do so. We’re not standing still in the fight against AMR.